Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.

Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sophie Eisenreich, Khalil Abou-El-Ardat, Karol Szafranski, Jaime A Campos Valenzuela, Andreas Rump, Janice M Nigro, Rolf Bjerkvig, Eva-Maria Gerlach, Karl Hackmann, Evelin Schröck, Dietmar Krex, Lars Kaderali, Gabriele Schackert, Matthias Platzer, Barbara Klink
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/801c70ba21a348528b99e6c36c4f4533
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:801c70ba21a348528b99e6c36c4f4533
record_format dspace
spelling oai:doaj.org-article:801c70ba21a348528b99e6c36c4f45332021-11-18T08:53:33ZNovel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.1932-620310.1371/journal.pone.0076623https://doaj.org/article/801c70ba21a348528b99e6c36c4f45332013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24086756/?tool=EBIhttps://doaj.org/toc/1932-6203Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role.Sophie EisenreichKhalil Abou-El-ArdatKarol SzafranskiJaime A Campos ValenzuelaAndreas RumpJanice M NigroRolf BjerkvigEva-Maria GerlachKarl HackmannEvelin SchröckDietmar KrexLars KaderaliGabriele SchackertMatthias PlatzerBarbara KlinkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e76623 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sophie Eisenreich
Khalil Abou-El-Ardat
Karol Szafranski
Jaime A Campos Valenzuela
Andreas Rump
Janice M Nigro
Rolf Bjerkvig
Eva-Maria Gerlach
Karl Hackmann
Evelin Schröck
Dietmar Krex
Lars Kaderali
Gabriele Schackert
Matthias Platzer
Barbara Klink
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
description Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role.
format article
author Sophie Eisenreich
Khalil Abou-El-Ardat
Karol Szafranski
Jaime A Campos Valenzuela
Andreas Rump
Janice M Nigro
Rolf Bjerkvig
Eva-Maria Gerlach
Karl Hackmann
Evelin Schröck
Dietmar Krex
Lars Kaderali
Gabriele Schackert
Matthias Platzer
Barbara Klink
author_facet Sophie Eisenreich
Khalil Abou-El-Ardat
Karol Szafranski
Jaime A Campos Valenzuela
Andreas Rump
Janice M Nigro
Rolf Bjerkvig
Eva-Maria Gerlach
Karl Hackmann
Evelin Schröck
Dietmar Krex
Lars Kaderali
Gabriele Schackert
Matthias Platzer
Barbara Klink
author_sort Sophie Eisenreich
title Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
title_short Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
title_full Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
title_fullStr Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
title_full_unstemmed Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
title_sort novel cic point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/801c70ba21a348528b99e6c36c4f4533
work_keys_str_mv AT sophieeisenreich novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT khalilabouelardat novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT karolszafranski novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT jaimeacamposvalenzuela novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT andreasrump novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT janicemnigro novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT rolfbjerkvig novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT evamariagerlach novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT karlhackmann novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT evelinschrock novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT dietmarkrex novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT larskaderali novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT gabrieleschackert novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT matthiasplatzer novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
AT barbaraklink novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing
_version_ 1718421212451831808